Acular LS Dosage
Generic name: KETOROLAC TROMETHAMINE 4mg in 1mL
Dosage form: ophthalmic solution
Drug class: Ophthalmic anti-inflammatory agents
Medically reviewed by Drugs.com. Last updated on Jun 21, 2024.
2.1 Recommended Dosing
The recommended dose of ACULAR LS ophthalmic solution is one drop four times a day in the operated eye as needed for pain and burning/stinging for up to 4 days following corneal refractive surgery.
2.2 Use With Other Topical Ophthalmic Medications
ACULAR LS has been safely administered in conjunction with other topical ophthalmic medications such as alpha-agonists, antibiotics, beta-blockers, carbonic anhydrase inhibitors, cycloplegics, and mydriatics. Drops should be administered at least 5 minutes apart.
More about Acular LS (ketorolac ophthalmic)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Side effects
- During pregnancy
- Generic availability
- Drug class: ophthalmic anti-inflammatory agents
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Other formulations
Related treatment guides
See also:
Lotemax
Lotemax and Lotemax SM (loteprednol etabonate) are corticosteroid medications used to help treat ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Patanol
Patanol (olopatadine) is used to treat eye allergy conditions, such as inflammation, itching and ...
Acular
Acular is used for corneal refractive surgery, postoperative ocular inflammation, seasonal allergic ...
Pataday Once Daily Relief
Pataday Once Daily Relief is used for seasonal allergic conjunctivitis
Eysuvis
Eysuvis (loteprednol etabonate) is a prescription corticosteroid eye drop used for the short-term ...
Pataday Twice Daily Relief
Pataday Twice Daily Relief is used for seasonal allergic conjunctivitis
Alrex
Alrex is used for conjunctivitis, cyclitis, iritis, keratitis, postoperative ocular inflammation ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
